340B program advocates recently took aim at a new Republican-requested Congressional Budget Office (CBO) report on the 340B program, arguing [...] …
Category: Legislative
A controversial GOP-backed plan to overhaul the 340B program continued to draw pushback from provider advocates—as well as muted or [...] …
A U.K.-based drugmaker recently announced it will soon exempt covered entities in two additional states from its 340B contract pharmacy [...] …
Breaking News
Carter, Harshbarger Reintroduce Controversial 340B ACCESS Act in U.S. House—This Time Without a Key Supporter
Two key U.S. House Republicans and vocal 340B program critics on Wednesday reintroduced controversial 340B overhaul legislation—but unlike last year’s [...] …
A tough-questioning federal appeals court panel yesterday held back-to-back oral arguments on drug industry legal challenges to Maryland and West [...] …
The Health Resources and Services Administration (HRSA) received more than 1,200 comments on its controversial 340B rebate pilot program ahead [...] …
A bipartisan group of 163 U.S. House members yesterday sent Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. [...] …
340B covered entities in the prime vendor program (PVP) spent nearly $44 billion on 340B drugs in 2021—up from $6.6 [...] …
A South Carolina Republican U.S. House lawmaker recently honored the life and legacy of Sue Veer, a nationally recognized leader [...] …
A bipartisan group of U.S. House members is circulating a draft letter urging the Department of Health and Human Services [...] …